Low doses of etanercept can be effective to maintain remission in ankylosing spondylitis patients

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism · 2003 · 762 citations

ASAS/EULAR recommendations for the management of ankylosing spondylitis

Jane Zochling · Annals of the Rheumatic Diseases · 2005 · 703 citations · Full text

Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate

C. Stephen Foster · Archives of Ophthalmology · 2003 · 217 citations

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

J. Brandt · British journal of rheumatology · 2004 · 154 citations

Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease

Victoria Navarro‐Compán, Virginia Moreira, Rafael Ariza‐Ariza et al. · Clinical Rheumatology · 2011 · 68 citations

Rheumatology, Spondyloarthritis, Rheumatic Diseases +9